Observational study on newly diagnosed diabetes and its complications

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize the clinical, metabolic, and immunological profiles of newly diagnosed adult patients with diabetes mellitus aged 18-69. It will monitor disease progression over time and compare the findings to a control group of glucose-tolerant individuals of similar demographics. Participants will undergo thorough examinations at baseline and follow-ups at 2, 5, and 10 years, with annual telephone contacts to gather additional data on their health status and lifestyle factors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of diabetes mellitus according to ADA criteria
* Age 18-69
* Diabetes duration since diagnosis \< 12 months
* Control cohort: proven normal glucose tolerance according to ADA criteria

Exclusion Criteria:

* Diabetes mellitus category 3 B-H (ADA criteria)
* Pregnancy
* Severe renal, liver or heart disease
* malignant cancer
* severe psychiatric illness or addiction
* participation in an intervention trial

Where it's running

• German Diabetes Center
  Düsseldorf, North Rhine-Westphalia, Germany Recruiting

Study contacts

• Principal investigator: Michael Roden, Prof., MD — German Diabetes Center
• Study coordinator: Robert Wagner, Prof., MD
• Email: robert.wagner@ddz.de
• Phone: +49-211-3382

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• Diabetes multimorbidity and a voice diary app to help self-manage

  This study tests whether the Fabla-diabetesMM audio diary app is feasible and helpful for older adults with type 1 or type 2 diabetes who also have additional chronic conditions.

  Recruiting Emory University · Atlanta, Georgia · NCT07474376

• Eversense Gemini system with new flash glucose feature — testing accuracy and safety

  This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.

  Recruiting Senseonics, Inc. · Escondido, California · NCT07386340

• Evaluating LY4057996 in Healthy Individuals and Those with Type 1 and Type 2 Diabetes

  This study is testing a new drug called LY4057996 to see how well it is tolerated and what side effects it might have in healthy people and those with Type 1 or Type 2 diabetes.

  Recruiting Phase 1 Eli Lilly and Company · Neuss · NCT06945406

• Comparing single-session and multiple-session laser treatment for diabetic eye disease

  This study is testing whether one session or multiple sessions of laser treatment works better for people with newly diagnosed diabetic eye disease to help them keep their vision and avoid complications.

  Recruiting Vastra Gotaland Region · Mölndal · NCT06549023

• Program to reduce food insecurity for hospitalized diabetics

  This study tests whether providing better access to healthy meals and nutrition education can help hospitalized patients with diabetes feel better and improve their overall health.

  Recruiting Stanford University · Palo Alto, California · NCT06329375

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.